Ryan Kraus

Ryan Kraus joined 1315 Capital in 2020. Previously, he worked as an Analyst at MTS Health Partners, focusing on M&A and financing transactions across the pharmaceutical, biotechnology, and healthcare services subsectors. Prior to MTS, Ryan worked at Pacira BioSciences in Corporate Strategy and Business Development.

Ryan serves on the board of CortiCare and as a board observer for 3B Scientific, CHC Solutions, Integration Health, Nu-Tek Bioscience, and SciSafe.

Ryan received a BS in Finance, summa cum laude, from Rutgers University.